+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Neutral Borosilicate Pharmaceutical Glass Bottles Market - Global Forecast 2026-2032

  • Report

  • 198 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6148385
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Neutral Borosilicate Pharmaceutical Glass Bottles Market is projected to reach USD 4.82 Billion in 2026. It is expected to continue growing at a CAGR of 6.68%, reaching USD 7.09 Billion by 2032.

Neutral Borosilicate Pharmaceutical Glass Bottles: Executive Overview

Neutral borosilicate pharmaceutical glass bottles are used for injectable medicines, vaccines, diagnostic products, and other formulations requiring strong chemical resistance, thermal stability, and low extractables. Their role is closely tied to product safety, container-closure integrity, sterilization compatibility, and regulatory compliance. Demand conditions are shaped by pharmaceutical manufacturing activity, biologics handling requirements, fill-finish capacity, and quality expectations across healthcare supply chains.

Regulatory, Sustainability, and Supply-Chain Shifts Reshaping Packaging

The landscape is moving toward tighter control of particulate contamination, delamination, dimensional consistency, and extractables and leachables. Pharmaceutical manufacturers are also placing greater emphasis on validated sterilization, traceability, breakage reduction, and reliable availability of primary packaging. Sustainability priorities are encouraging lighter designs, higher recycled-content consideration where technically appropriate, energy-efficient production, and improved logistics, while these initiatives must remain compatible with stringent pharmaceutical quality requirements.

Artificial Intelligence Strengthens Quality, Planning, and Manufacturing Control

Artificial intelligence is increasingly relevant to inspection and operational decision-making rather than replacing regulated quality systems. Machine-vision models can support detection of cosmetic defects, dimensional deviations, cracks, and foreign particles, while predictive analytics can help identify process drift and maintenance needs. AI can also improve demand sensing, production scheduling, inventory allocation, and deviation investigation. Successful deployment depends on validated data, human oversight, cybersecurity, documented model changes, and alignment with good manufacturing and data-integrity practices.

Regional Insights: Regulation and Pharmaceutical Manufacturing Shape Adoption

North America is characterized by demanding quality expectations, established injectable-drug production, and strong attention to container-closure integrity. Latin America reflects expanding pharmaceutical capabilities alongside varied regulatory and logistics environments. Europe emphasizes harmonized quality requirements, sustainability, recycling, and advanced manufacturing practices. The Middle East is developing healthcare and pharmaceutical infrastructure, with supply continuity and import resilience remaining important. Africa presents diverse access, manufacturing, and distribution conditions, making robust packaging and dependable logistics especially valuable. Asia-Pacific combines major pharmaceutical production hubs, growing healthcare demand, and expanding local fill-finish capacity, with quality harmonization and supply-chain localization shaping purchasing decisions.

Group Insights: Trade, Standards, and Industrial Policy Influence Packaging Needs

ASEAN markets are linked by regional manufacturing networks and efforts to improve pharmaceutical supply resilience, although regulatory implementation varies. BRICS economies combine substantial pharmaceutical demand with growing domestic production and localization priorities. The European Union places strong emphasis on coordinated regulation, quality assurance, environmental performance, and circular-economy objectives. G7 markets generally maintain mature pharmaceutical quality systems and advanced packaging requirements. GCC countries are investing in healthcare capacity and pharmaceutical security, increasing the importance of dependable primary-packaging supply. NATO members span diverse production bases, but shared resilience concerns support attention to strategic inventories, qualified suppliers, and secure logistics.

Country Insights: Diverse Production Bases Require Localized Commercial Priorities

Australia combines rigorous medicines oversight with reliance on international manufacturing and distribution networks. Brazil has a large healthcare system and domestic pharmaceutical capabilities, while regulatory and logistics complexity remains relevant. Canada emphasizes stringent quality expectations and integrated North American supply chains. China has extensive pharmaceutical manufacturing capacity and continues to strengthen domestic supply networks. France, Germany, Italy, and Spain operate within the European regulatory framework and support advanced pharmaceutical and packaging ecosystems, with sustainability and compliance prominent. India is a major medicines producer with broad fill-finish activity and strong cost and scale considerations. Japan prioritizes high consistency, reliability, and process control. Mexico benefits from proximity to North American manufacturing while serving domestic and export-oriented production. Russia’s pharmaceutical supply environment is influenced by localization and import constraints. South Korea combines advanced biopharmaceutical manufacturing with strong quality requirements. The United Kingdom maintains rigorous pharmaceutical standards and specialized manufacturing capabilities. The United States has extensive injectable-drug and healthcare infrastructure, with regulatory compliance, supply continuity, and inspection performance central to procurement.

Action Priorities for Leaders in Pharmaceutical Glass Packaging

Leaders should qualify more than one reliable source where regulations and product specifications permit, while preserving strict change-control discipline. They should connect bottle design decisions with formulation compatibility, sterilization method, filling speed, closure performance, and transport conditions. Investment priorities should include automated inspection, defect analytics, furnace and forming-process control, traceability, and validated digital quality systems. Procurement and operations teams should map regional dependencies, maintain risk-based safety stocks for critical formats, and establish clear escalation procedures for quality or supply disruptions. Sustainability programs should measure lifecycle effects and avoid design changes that compromise container performance.

Research Methodology: Evidence-Based Market Interpretation

This executive summary interprets the specified market category-neutral borosilicate pharmaceutical glass bottles-through a structured review of application requirements, pharmaceutical packaging standards, manufacturing considerations, regional operating conditions, and macro-level supply-chain dynamics. Insights are organized across the required regions, economic and political groups, and countries. The analysis emphasizes verifiable industry drivers and constraints while excluding market estimates, shares, forecasts, and company-specific claims. Conclusions should be validated against current regulatory publications, pharmacopeial requirements, customer specifications, and primary interviews before use in investment or procurement decisions.

Conclusion: Quality Assurance and Resilient Supply Will Define Competitive Advantage

Neutral borosilicate pharmaceutical glass bottles remain a critical primary-packaging component where chemical stability, thermal performance, and container integrity directly support medicine quality. The most durable opportunities are linked to reliable compliance, consistent production, transparent traceability, and the ability to serve differing regional requirements. Manufacturers and pharmaceutical buyers that combine validated quality systems with resilient sourcing, responsible material strategies, and carefully governed digital tools will be better positioned to manage evolving regulatory, operational, and sustainability expectations.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Neutral Borosilicate Pharmaceutical Glass Bottles Market, by Product Type
7.1. Introduction
7.2. Ampoule
7.3. Bottle
7.4. Cartridge
7.5. Prefilled Syringe
7.6. Vial
8. Neutral Borosilicate Pharmaceutical Glass Bottles Market, by Closure Type
8.1. Introduction
8.2. Crimp Seal
8.3. Flip-Off Cap
8.4. Rubber Stopper
8.5. Screw Cap
9. Neutral Borosilicate Pharmaceutical Glass Bottles Market, by Functionality
9.1. Introduction
9.2. Preservative Free
9.3. Pyrogen Free
9.4. Sterile
9.5. Vacuum
10. Neutral Borosilicate Pharmaceutical Glass Bottles Market, by Application
10.1. Introduction
10.2. Injectable
10.2.1. Intradermal
10.2.2. Intramuscular
10.2.3. Intravenous
10.2.4. Subcutaneous
10.3. Lyophilized Product
10.3.1. Antibiotic
10.3.2. Protein
10.3.3. Vaccine
10.4. Ophthalmic Solution
10.5. Oral Liquid
11. Neutral Borosilicate Pharmaceutical Glass Bottles Market, by End Use
11.1. Introduction
11.2. Clinic
11.3. Hospital
11.4. Pharmaceutical Company
11.5. Research Laboratory
12. Neutral Borosilicate Pharmaceutical Glass Bottles Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Neutral Borosilicate Pharmaceutical Glass Bottles Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Neutral Borosilicate Pharmaceutical Glass Bottles Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Bormioli Pharma S.p.A.
16.2. Corning Incorporated
16.3. Gerresheimer AG
16.4. Nampak Glass (Pty) Limited
16.5. Nippon Electric Glass Co., Ltd.
16.6. Nipro Corporation
16.7. Owens-Illinois, Inc.
16.8. Piramal Glass Limited
16.9. Schott AG
16.10. SGD Pharma SAS
16.11. Stevanato Group S.p.A.
16.12. Vitro, S.A.B. de C.V.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Neutral Borosilicate Pharmaceutical Glass Bottles Market, Years Considered for the Study
FIGURE 2. Global Neutral Borosilicate Pharmaceutical Glass Bottles Market, Research Design
FIGURE 3. Global Neutral Borosilicate Pharmaceutical Glass Bottles Market, Research Framework
FIGURE 4. Global Neutral Borosilicate Pharmaceutical Glass Bottles Market, Data Triangulation
FIGURE 5. Global Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Closure Type, 2025 vs 2032 (%)
FIGURE 9. Global Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Closure Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Functionality, 2025 vs 2032 (%)
FIGURE 11. Global Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Functionality, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by End Use, 2025 vs 2032 (%)
FIGURE 15. Global Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by End Use, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Neutral Borosilicate Pharmaceutical Glass Bottles Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Neutral Borosilicate Pharmaceutical Glass Bottles Market Segmentation & Coverage
TABLE 2. Global Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, 2017-2032 (USD Million)
TABLE 3. Global Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Ampoule Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Ampoule Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Ampoule Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Bottle Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Bottle Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Bottle Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Cartridge Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Cartridge Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Cartridge Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Prefilled Syringe Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Prefilled Syringe Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Prefilled Syringe Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Vial Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Vial Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Vial Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Closure Type, 2017-2032 (USD Million)
TABLE 20. Global Crimp Seal Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Crimp Seal Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Crimp Seal Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Flip-Off Cap Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Flip-Off Cap Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Flip-Off Cap Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Rubber Stopper Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Rubber Stopper Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Rubber Stopper Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Screw Cap Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Screw Cap Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Screw Cap Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 33. Global Preservative Free Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Preservative Free Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Preservative Free Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Pyrogen Free Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Pyrogen Free Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Pyrogen Free Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Sterile Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Sterile Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Sterile Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Vacuum Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Vacuum Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Vacuum Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Application, 2017-2032 (USD Million)
TABLE 46. Global Injectable Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Injectable Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Injectable Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Intradermal Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Intradermal Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Intradermal Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Intramuscular Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Intramuscular Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Intramuscular Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Intravenous Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Intravenous Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Intravenous Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Subcutaneous Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Subcutaneous Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Subcutaneous Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Lyophilized Product Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Lyophilized Product Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Lyophilized Product Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Antibiotic Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Antibiotic Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Antibiotic Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Protein Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Protein Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Protein Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Ophthalmic Solution Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Ophthalmic Solution Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Ophthalmic Solution Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Oral Liquid Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Oral Liquid Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Oral Liquid Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by End Use, 2017-2032 (USD Million)
TABLE 80. Global Clinic Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Clinic Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Clinic Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Hospital Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Hospital Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Hospital Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Pharmaceutical Company Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Pharmaceutical Company Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Pharmaceutical Company Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global Research Laboratory Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Global Research Laboratory Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. Global Research Laboratory Market Size, by Country, 2017-2032 (USD Million)
TABLE 92. Global Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Asia-Pacific Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Asia-Pacific Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 95. Asia-Pacific Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Closure Type, 2017-2032 (USD Million)
TABLE 96. Asia-Pacific Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 97. Asia-Pacific Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Application, 2017-2032 (USD Million)
TABLE 98. Asia-Pacific Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 99. Asia-Pacific Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Lyophilized Product, 2017-2032 (USD Million)
TABLE 100. Asia-Pacific Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by End Use, 2017-2032 (USD Million)
TABLE 101. North America Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. North America Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 103. North America Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Closure Type, 2017-2032 (USD Million)
TABLE 104. North America Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 105. North America Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Application, 2017-2032 (USD Million)
TABLE 106. North America Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 107. North America Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Lyophilized Product, 2017-2032 (USD Million)
TABLE 108. North America Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by End Use, 2017-2032 (USD Million)
TABLE 109. Latin America Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Latin America Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 111. Latin America Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Closure Type, 2017-2032 (USD Million)
TABLE 112. Latin America Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 113. Latin America Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Application, 2017-2032 (USD Million)
TABLE 114. Latin America Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 115. Latin America Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Lyophilized Product, 2017-2032 (USD Million)
TABLE 116. Latin America Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by End Use, 2017-2032 (USD Million)
TABLE 117. Europe Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Region, 2017-2032 (USD Million)
TABLE 118. Europe Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 119. Europe Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Closure Type, 2017-2032 (USD Million)
TABLE 120. Europe Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 121. Europe Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Application, 2017-2032 (USD Million)
TABLE 122. Europe Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 123. Europe Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Lyophilized Product, 2017-2032 (USD Million)
TABLE 124. Europe Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by End Use, 2017-2032 (USD Million)
TABLE 125. Middle East Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Region, 2017-2032 (USD Million)
TABLE 126. Middle East Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 127. Middle East Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Closure Type, 2017-2032 (USD Million)
TABLE 128. Middle East Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 129. Middle East Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Application, 2017-2032 (USD Million)
TABLE 130. Middle East Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 131. Middle East Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Lyophilized Product, 2017-2032 (USD Million)
TABLE 132. Middle East Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by End Use, 2017-2032 (USD Million)
TABLE 133. Africa Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Region, 2017-2032 (USD Million)
TABLE 134. Africa Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 135. Africa Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Closure Type, 2017-2032 (USD Million)
TABLE 136. Africa Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 137. Africa Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Application, 2017-2032 (USD Million)
TABLE 138. Africa Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 139. Africa Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Lyophilized Product, 2017-2032 (USD Million)
TABLE 140. Africa Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by End Use, 2017-2032 (USD Million)
TABLE 141. Global Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Group, 2017-2032 (USD Million)
TABLE 142. ASEAN Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Group, 2017-2032 (USD Million)
TABLE 143. ASEAN Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 144. ASEAN Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Closure Type, 2017-2032 (USD Million)
TABLE 145. ASEAN Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 146. ASEAN Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Application, 2017-2032 (USD Million)
TABLE 147. ASEAN Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 148. ASEAN Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Lyophilized Product, 2017-2032 (USD Million)
TABLE 149. ASEAN Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by End Use, 2017-2032 (USD Million)
TABLE 150. GCC Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Group, 2017-2032 (USD Million)
TABLE 151. GCC Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 152. GCC Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Closure Type, 2017-2032 (USD Million)
TABLE 153. GCC Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 154. GCC Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Application, 2017-2032 (USD Million)
TABLE 155. GCC Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 156. GCC Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Lyophilized Product, 2017-2032 (USD Million)
TABLE 157. GCC Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by End Use, 2017-2032 (USD Million)
TABLE 158. European Union Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Group, 2017-2032 (USD Million)
TABLE 159. European Union Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 160. European Union Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Closure Type, 2017-2032 (USD Million)
TABLE 161. European Union Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 162. European Union Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Application, 2017-2032 (USD Million)
TABLE 163. European Union Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 164. European Union Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Lyophilized Product, 2017-2032 (USD Million)
TABLE 165. European Union Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by End Use, 2017-2032 (USD Million)
TABLE 166. BRICS Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Group, 2017-2032 (USD Million)
TABLE 167. BRICS Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 168. BRICS Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Closure Type, 2017-2032 (USD Million)
TABLE 169. BRICS Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 170. BRICS Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Application, 2017-2032 (USD Million)
TABLE 171. BRICS Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 172. BRICS Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Lyophilized Product, 2017-2032 (USD Million)
TABLE 173. BRICS Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by End Use, 2017-2032 (USD Million)
TABLE 174. G7 Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Group, 2017-2032 (USD Million)
TABLE 175. G7 Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 176. G7 Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Closure Type, 2017-2032 (USD Million)
TABLE 177. G7 Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 178. G7 Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Application, 2017-2032 (USD Million)
TABLE 179. G7 Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 180. G7 Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Lyophilized Product, 2017-2032 (USD Million)
TABLE 181. G7 Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by End Use, 2017-2032 (USD Million)
TABLE 182. NATO Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Group, 2017-2032 (USD Million)
TABLE 183. NATO Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 184. NATO Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Closure Type, 2017-2032 (USD Million)
TABLE 185. NATO Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 186. NATO Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Application, 2017-2032 (USD Million)
TABLE 187. NATO Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 188. NATO Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Lyophilized Product, 2017-2032 (USD Million)
TABLE 189. NATO Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by End Use, 2017-2032 (USD Million)
TABLE 190. Global Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Country, 2017-2032 (USD Million)
TABLE 191. United States Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, 2017-2032 (USD Million)
TABLE 192. United States Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 193. United States Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Closure Type, 2017-2032 (USD Million)
TABLE 194. United States Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 195. United States Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Application, 2017-2032 (USD Million)
TABLE 196. United States Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 197. United States Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Lyophilized Product, 2017-2032 (USD Million)
TABLE 198. United States Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by End Use, 2017-2032 (USD Million)
TABLE 199. Canada Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, 2017-2032 (USD Million)
TABLE 200. Canada Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 201. Canada Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Closure Type, 2017-2032 (USD Million)
TABLE 202. Canada Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 203. Canada Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Application, 2017-2032 (USD Million)
TABLE 204. Canada Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 205. Canada Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Lyophilized Product, 2017-2032 (USD Million)
TABLE 206. Canada Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by End Use, 2017-2032 (USD Million)
TABLE 207. Mexico Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, 2017-2032 (USD Million)
TABLE 208. Mexico Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 209. Mexico Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Closure Type, 2017-2032 (USD Million)
TABLE 210. Mexico Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 211. Mexico Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Application, 2017-2032 (USD Million)
TABLE 212. Mexico Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 213. Mexico Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Lyophilized Product, 2017-2032 (USD Million)
TABLE 214. Mexico Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by End Use, 2017-2032 (USD Million)
TABLE 215. Brazil Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, 2017-2032 (USD Million)
TABLE 216. Brazil Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 217. Brazil Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Closure Type, 2017-2032 (USD Million)
TABLE 218. Brazil Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 219. Brazil Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Application, 2017-2032 (USD Million)
TABLE 220. Brazil Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 221. Brazil Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Lyophilized Product, 2017-2032 (USD Million)
TABLE 222. Brazil Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by End Use, 2017-2032 (USD Million)
TABLE 223. United Kingdom Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, 2017-2032 (USD Million)
TABLE 224. United Kingdom Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 225. United Kingdom Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Closure Type, 2017-2032 (USD Million)
TABLE 226. United Kingdom Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 227. United Kingdom Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Application, 2017-2032 (USD Million)
TABLE 228. United Kingdom Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 229. United Kingdom Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Lyophilized Product, 2017-2032 (USD Million)
TABLE 230. United Kingdom Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by End Use, 2017-2032 (USD Million)
TABLE 231. Germany Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, 2017-2032 (USD Million)
TABLE 232. Germany Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 233. Germany Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Closure Type, 2017-2032 (USD Million)
TABLE 234. Germany Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 235. Germany Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Application, 2017-2032 (USD Million)
TABLE 236. Germany Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 237. Germany Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Lyophilized Product, 2017-2032 (USD Million)
TABLE 238. Germany Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by End Use, 2017-2032 (USD Million)
TABLE 239. France Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, 2017-2032 (USD Million)
TABLE 240. France Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 241. France Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Closure Type, 2017-2032 (USD Million)
TABLE 242. France Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 243. France Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Application, 2017-2032 (USD Million)
TABLE 244. France Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 245. France Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Lyophilized Product, 2017-2032 (USD Million)
TABLE 246. France Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by End Use, 2017-2032 (USD Million)
TABLE 247. Russia Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, 2017-2032 (USD Million)
TABLE 248. Russia Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 249. Russia Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Closure Type, 2017-2032 (USD Million)
TABLE 250. Russia Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 251. Russia Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Application, 2017-2032 (USD Million)
TABLE 252. Russia Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 253. Russia Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Lyophilized Product, 2017-2032 (USD Million)
TABLE 254. Russia Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by End Use, 2017-2032 (USD Million)
TABLE 255. Italy Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, 2017-2032 (USD Million)
TABLE 256. Italy Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 257. Italy Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Closure Type, 2017-2032 (USD Million)
TABLE 258. Italy Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 259. Italy Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Application, 2017-2032 (USD Million)
TABLE 260. Italy Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 261. Italy Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Lyophilized Product, 2017-2032 (USD Million)
TABLE 262. Italy Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by End Use, 2017-2032 (USD Million)
TABLE 263. Spain Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, 2017-2032 (USD Million)
TABLE 264. Spain Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 265. Spain Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Closure Type, 2017-2032 (USD Million)
TABLE 266. Spain Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 267. Spain Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Application, 2017-2032 (USD Million)
TABLE 268. Spain Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 269. Spain Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Lyophilized Product, 2017-2032 (USD Million)
TABLE 270. Spain Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by End Use, 2017-2032 (USD Million)
TABLE 271. China Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, 2017-2032 (USD Million)
TABLE 272. China Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 273. China Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Closure Type, 2017-2032 (USD Million)
TABLE 274. China Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 275. China Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Application, 2017-2032 (USD Million)
TABLE 276. China Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 277. China Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Lyophilized Product, 2017-2032 (USD Million)
TABLE 278. China Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by End Use, 2017-2032 (USD Million)
TABLE 279. India Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, 2017-2032 (USD Million)
TABLE 280. India Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 281. India Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Closure Type, 2017-2032 (USD Million)
TABLE 282. India Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 283. India Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Application, 2017-2032 (USD Million)
TABLE 284. India Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 285. India Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Lyophilized Product, 2017-2032 (USD Million)
TABLE 286. India Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by End Use, 2017-2032 (USD Million)
TABLE 287. Japan Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, 2017-2032 (USD Million)
TABLE 288. Japan Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 289. Japan Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Closure Type, 2017-2032 (USD Million)
TABLE 290. Japan Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 291. Japan Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Application, 2017-2032 (USD Million)
TABLE 292. Japan Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 293. Japan Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Lyophilized Product, 2017-2032 (USD Million)
TABLE 294. Japan Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by End Use, 2017-2032 (USD Million)
TABLE 295. Australia Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, 2017-2032 (USD Million)
TABLE 296. Australia Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 297. Australia Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Closure Type, 2017-2032 (USD Million)
TABLE 298. Australia Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 299. Australia Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Application, 2017-2032 (USD Million)
TABLE 300. Australia Neutral Borosilicate Pharmaceutical Glass Bottles Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 301. Australia Neutral Borosilicate Pharm

Companies Mentioned

  • Bormioli Pharma S.p.A.
  • Corning Incorporated
  • Gerresheimer AG
  • Nampak Glass (Pty) Limited
  • Nippon Electric Glass Co., Ltd.
  • Nipro Corporation
  • Owens-Illinois, Inc.
  • Piramal Glass Limited
  • Schott AG
  • SGD Pharma SAS
  • Stevanato Group S.p.A.
  • Vitro, S.A.B. de C.V.